A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for …

RK Hoyles, RW Ellis, J Wellsbury… - … : Official Journal of …, 2006 - Wiley Online Library
Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was …

Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study

…, LP Ho, RK Hoyles, J Hutchinson, K Hurley… - American journal of …, 2020 - atsjournals.org
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …

Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis

NS Goh, RK Hoyles, CP Denton… - Arthritis & …, 2017 - Wiley Online Library
Objective To determine the prognostic value of pulmonary function test (PFT) trends at 1 and
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled …

…, S Barratt, H Gunawardena, RK Hoyles… - The Lancet …, 2023 - thelancet.com
Background Interstitial lung disease is a known complication of rheumatoid arthritis, with a
lifetime risk of developing the disease in any individual of 7·7%. We aimed to assess the safety…

Pivotal role of connective tissue growth factor in lung fibrosis: MAPK‐dependent transcriptional activation of type I collagen

…, K Khan, VS Rajkumar, RK Hoyles… - … : Official Journal of …, 2009 - Wiley Online Library
Objective Connective tissue growth factor (CTGF; CCN2) is overexpressed in systemic
sclerosis (SSc) and has been hypothesized to be a key mediator of the pulmonary fibrosis …

[HTML][HTML] British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of …

…, SP Hart, GR Hayman, R Herriot, RK Hoyles… - The Journal of Allergy …, 2017 - Elsevier
A proportion of people living with common variable immunodeficiency disorders develop
granulomatous-lymphocytic interstitial lung disease (GLILD). We aimed to develop a …

An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptor

RK Hoyles, EC Derrett-Smith, K Khan… - American journal of …, 2011 - atsjournals.org
Rationale: Fibrotic response to lung injury depends on development of a fibrogenic
population of myofibroblasts. The importance of resident interstitial fibroblasts and role of …

[HTML][HTML] Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double …

…, SV Fletcher, CP Denton, RK Hoyles… - The Lancet …, 2023 - thelancet.com
Background Rituximab is often used as rescue therapy in interstitial lung disease (ILD)
associated with connective tissue disease (CTD), but has not been studied in clinical trials. This …

[HTML][HTML] Inducible lineage-specific deletion of TβRII in fibroblasts defines a pivotal regulatory role during adult skin wound healing

CP Denton, K Khan, RK Hoyles, X Shiwen… - Journal of investigative …, 2009 - Elsevier
Previous attempts to delete type II TGFβ receptor (TβRII) in fibroblasts have precluded
examination of adult mice due to early mortality. We have selectively deleted TβRII postnatally in …

Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis

…, R Benamore, RK Hoyles… - BMJ Open …, 2022 - bmjopenrespres.bmj.com
Rationale Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease. Patients
present at different stages and disease course is varied. Blood monocytes have been linked …